Scenario-Driven Solutions with AZ505, a Potent and Select...
2026-01-23
This article addresses practical laboratory challenges in cell viability, proliferation, and cytotoxicity assays, focusing on the evidence-backed applications of AZ505, a potent and selective SMYD2 inhibitor (SKU B1255). Drawing from peer-reviewed data and validated workflows, it guides biomedical researchers in optimizing experimental design, protocol execution, and vendor selection for robust epigenetic regulation research.
KU-60019: Selective ATM Kinase Inhibitor for Radiosensiti...
2026-01-22
KU-60019 is a highly potent and selective ATM kinase inhibitor used to radiosensitize glioma and other cancer cells. Its effectiveness in suppressing prosurvival signaling and enhancing DNA damage response inhibition makes it a critical tool for cancer research.
(-)-JQ1: Definitive Inactive Control for BET Bromodomain ...
2026-01-22
(-)-JQ1 is the gold-standard inactive control for BET bromodomain inhibition in epigenetics and cancer biology research. Unlike its active stereoisomer (+)-JQ1, (-)-JQ1 demonstrates negligible BET binding and is essential for validating target specificity in BRD4-dependent assays.
Nicotinamide Riboside Chloride (NIAGEN): Unlocking Precis...
2026-01-21
Discover how Nicotinamide Riboside Chloride, a potent NAD+ metabolism enhancer, is redefining metabolic dysfunction and neurodegenerative disease models. This article uniquely explores its mechanistic role in sirtuin activation and stem cell-derived retinal ganglion cell regeneration.
Redefining the Translational Frontier: Mechanistic and St...
2026-01-21
Explore the evolving landscape of CXCR4 chemokine receptor antagonism with Plerixafor (AMD3100). This thought-leadership article offers mechanistic insight into the SDF-1/CXCL12–CXCR4 axis, evaluates recent comparative research in cancer models, and provides strategic recommendations for translational researchers seeking to optimize experimental design and bridge preclinical findings with clinical potential.
From Precision Photosynthesis Inhibition to Translational...
2026-01-20
This thought-leadership article examines Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) as a benchmark herbicide research chemical, spotlighting its dual utility in photosystem II inhibition and as a model for environmental nephrotoxicity. Integrating recent mechanistic insights—especially the JAK2/STAT1-mediated acute kidney injury pathway—this piece delivers actionable guidance for translational researchers seeking to leverage high-purity Diuron from APExBIO in advanced plant biology, environmental toxicology, and cross-kingdom toxicodynamics studies.
WM-8014: Selective KAT6A/KAT6B Inhibitor for Epigenetic R...
2026-01-20
WM-8014 is a highly selective histone acetyltransferase inhibitor targeting KAT6A and KAT6B. This compound enables precise modulation of oncogene-induced senescence via the p16INK4A–p19ARF pathway, supporting cancer biology and epigenetic drug target research.
457 records 31/31 page Previous First page 上5页 31